Although most cell therapies focus on CD8+ CTLs due to their tumor killing capabilities, considering the molecular ‘help’ by CD4+ TH cells is required for CD8+ cytotoxicity and recruitment, adoptive transfer of CD4+ T cells may play an important role in overall tumor immune response (84). Here, CD8A is linked to neoplasm.